Given changes in patient characteristics and treatments over time, a contemporary risk model for patients with acute myocardial infarction (MI) is needed. Data from 313 825 acute MI hospitalizations ...

In the ABYSS (Assessment of Beta-Blocker Interruption 1 Year After an Uncomplicated Myocardial Infarction on Safety and Symptomatic Cardiac Events Requiring Hospitalization) trial, interruption of ...

Acute myocardial infarction (AMI) remains a leading cause of mortality and morbidity worldwide, accounting for approximately 40%–50% of sudden cardiac deaths (Rallidis et al., 2022). Although prompt ...